Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals.

<h4>Background</h4>Direct-acting antivirals (DAAs) are effective in patients aged ≥65 years. However, little is known about the effects of DAAs on survival, liver decompensation and development of hepatocellular carcinoma (HCC).<h4>Objective</h4>To compare the incidence of li...

Full description

Bibliographic Details
Main Authors: Iria Rodríguez-Osorio, Alvaro Mena, Héctor Meijide, Luis Morano, Manuel Delgado, Purificación Cid, Luis Margusino, José Domingo Pedreira, Ángeles Castro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217052